These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 15476223

  • 1. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group.
    Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, Huong DL, Denjoy I, Vauthier D, Sebbouh D, Fain O, Georgin-Lavialle S, Ghillani P, Musset L, Wechsler B, Duhaut P, Piette JC.
    Arthritis Rheum; 2004 Oct; 50(10):3187-94. PubMed ID: 15476223
    [Abstract] [Full Text] [Related]

  • 2. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases.
    Lazzerini PE, Acampa M, Guideri F, Capecchi PL, Campanella V, Morozzi G, Galeazzi M, Marcolongo R, Laghi-Pasini F.
    Arthritis Rheum; 2004 Apr; 50(4):1248-52. PubMed ID: 15077308
    [Abstract] [Full Text] [Related]

  • 3. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study.
    Gerosa M, Cimaz R, Stramba-Badiale M, Goulene K, Meregalli E, Trespidi L, Acaia B, Cattaneo R, Tincani A, Motta M, Doria A, Zulian F, Milanesi O, Brucato A, Riboldi P, Meroni PL.
    Rheumatology (Oxford); 2007 Aug; 46(8):1285-9. PubMed ID: 17449486
    [Abstract] [Full Text] [Related]

  • 4. Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease.
    Lazzerini PE, Capecchi PL, Guideri F, Bellisai F, Selvi E, Acampa M, Costa A, Maggio R, Garcia-Gonzalez E, Bisogno S, Morozzi G, Galeazzi M, Laghi-Pasini F.
    Am J Cardiol; 2007 Sep 15; 100(6):1029-34. PubMed ID: 17826392
    [Abstract] [Full Text] [Related]

  • 5. Outcome of infants from mothers with anti-SSA/Ro antibodies.
    Motta M, Rodriguez-Perez C, Tincani A, Lojacono A, Chirico G.
    J Perinatol; 2007 May 15; 27(5):278-83. PubMed ID: 17363909
    [Abstract] [Full Text] [Related]

  • 6. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
    Julkunen H, Miettinen A, Walle TK, Chan EK, Eronen M.
    J Rheumatol; 2004 Jan 15; 31(1):183-9. PubMed ID: 14705240
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term outcome of mothers of children with complete congenital heart block.
    Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM, Silverman ED.
    Am J Med; 1996 Mar 15; 100(3):328-32. PubMed ID: 8629679
    [Abstract] [Full Text] [Related]

  • 9. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE, Caldwell K, Feit S, Chan EK, Buyon JP.
    J Rheumatol; 1996 May 15; 23(5):925-32. PubMed ID: 8724310
    [Abstract] [Full Text] [Related]

  • 10. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D, Elchalal U, Rein AJ.
    Curr Opin Rheumatol; 2009 Sep 15; 21(5):478-82. PubMed ID: 19584727
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity.
    Lazzerini PE, Capecchi PL, Acampa M, Morozzi G, Bellisai F, Bacarelli MR, Dragoni S, Fineschi I, Simpatico A, Galeazzi M, Laghi-Pasini F.
    Arthritis Care Res (Hoboken); 2011 Oct 15; 63(10):1463-70. PubMed ID: 21739618
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.
    Costedoat-Chalumeau N, Amoura Z, Duhaut P, Huong DL, Sebbough D, Wechsler B, Vauthier D, Denjoy I, Lupoglazoff JM, Piette JC.
    Arthritis Rheum; 2003 Nov 15; 48(11):3207-11. PubMed ID: 14613284
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.
    Friedman DM, Kim MY, Copel JA, Davis C, Phoon CK, Glickstein JS, Buyon JP, PRIDE Investigators.
    Circulation; 2008 Jan 29; 117(4):485-93. PubMed ID: 18195175
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
    Chang YL, Hsieh PC, Chang SD, Chao AS, Liang CC, Soong YK.
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct 01; 122(2):167-71. PubMed ID: 16219517
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.